Gaudium IVF and Women Health
GAUDIUMIVFNSE

Gaudium IVF and Women Health

₹103.640.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
103.64
Today’s high
105.65
52 week low
69.18
52 week high
133.00
Open price
105.65
Previous close
103.64
Live volume
--
Lower circuit
101.57
Upper circuit
105.71

Fundamentals

Market Cap
₹766Cr
ROE
16.08%
P/E Ratio(TTM)
31.34
EPS(TTM)
3.36
P/B Ratio
5.03
Dividend Yield
0.00%
Industry P/E
59.84
Book Value
20.92
Debt to Equity
0.16
Face Value
5

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹30.53
+24.06%
Profit (Cr)
₹8.36
+130.30%
010203040
Dec '24
Mar '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+112%
3Y CAGR+25%
Profit growthValue
1Y (TTM)+146%
3Y CAGR+29%

About

Gaudium IVF and Women Health is a leading provider of Assisted Reproductive Technology (ART) and In-Vitro Fertilization (IVF) treatments in India. Established with a patient-centric approach, the company operates using a "Hub and Spoke" model to maximize its reach. It provides services across IVF, ICSI (Intracytoplasmic Sperm Injection), IUI (Intrauterine Insemination), egg/sperm donation, Comprehensive care for PCOD/PCOS, endometriosis, and high-risk pregnancy management.;
CEO/MD
Dr. Manika Khanna
Founded in
2015
NSE symbol
GAUDIUMIVF

Shareholding Pattern

Jan '25
Sep '25
Feb '26
Mar '26
Promoters
71.29%
Retail And Others
19.39%
Foreign Institutions
6.70%
Other Domestic Institutions
2.62%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹8,488.50
0.00 (--)
L
    H
    1,22,585.0561.2112.94
    ₹1,010.10
    0.00 (--)
    L
      H
      97,640.6867.79.09
      ₹989.00
      0.00 (--)
      L
        H
        74,771.0570.247.56
        ₹812.90
        0.00 (--)
        L
          H
          40,944.5195.99.69
          Livesquawk
          Gaudium IVF Q4 net profit rose 29% YoY to ₹84M from ₹65M. Q4 revenue increased 13% YoY to ₹304M from ₹269M.
          Livesquawk
          Gaudium IVF plans 10 IVF hubs in FY27, 8 in FY28, and 1 in FY29. The expansion of 19 hubs will be funded through IPO proceeds.
          Livesquawk
          Mukul Agrawal acquired a 3.4% stake in Gaudium IVF during Q4. He purchased 25 lakh shares of Gaudium IVF and Women Health Ltd.
          Livesquawk
          Gaudium IVF reports Q3 net profit of ₹36M, up from ₹34M YoY. Revenue surged to ₹245M in Q3, compared to ₹144M YoY.
          2026
          28
          May
          Annual Result
          Release date
          18
          Mar
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks